HomeCanada
Peptide status in Canada
Of the 45 peptides on this site, 5 have a product authorized by Health Canada: HCG, HGH, HMG, Semaglutide and Tirzepatide. The rest have no marketed product in the Drug Product Database. Checked 10 Oct 2026.
Canada
Authorized 5
Not authorized 40
Checked 10 Oct 2026Status of each peptide in Canada
| Peptide | Canada | What was found | US |
|---|---|---|---|
| 5-Amino-1MQ | Not authorized | No product is in the Health Canada Drug Product Database. A product labelled 5-AMINO-IMQ was among unauthorized products Health Canada seized. Source | Not approved |
| AOD-9604 | Not authorized | No AOD-9604 product is in the Health Canada Drug Product Database. Health Canada names AOD9604 among unauthorized injectable peptide drugs it has seized. Source | Not approved |
| ARA-290 | Not authorized | No ARA-290 or cibinetide product is in Health Canada's Drug Product Database, and Health Canada lists ARA 290 among unauthorized injectable peptide drugs seized from an online seller. Source | Not approved |
| BPC-157 | Not authorized | Not authorized in Canada. Health Canada names BPC-157 among unauthorized injectable peptide drugs it has seized (advisory of 9 April 2026). Source | Not approved |
| Cagrilintide | Not authorized | No cagrilintide product is in the Health Canada Drug Product Database. Source | Not approved, in trials |
| Cardiogen | Not authorized | No Cardiogen product is in the Health Canada Drug Product Database. Health Canada warns against all unauthorized injectable peptide drugs. Source | Not approved |
| Cartalax | Not authorized | No Cartalax product, current or cancelled, is in Health Canada's Drug Product Database. Injectable peptides are regulated as prescription drugs in Canada. Source | Not approved |
| CJC-1295 with DAC | Not authorized | No CJC-1295 product is in Health Canada's Drug Product Database, and Health Canada names CJC-1295 among unauthorized injectable peptide drugs it has seized. Source | Not approved |
| CJC-1295 without DAC | Not authorized | No product under CJC-1295 or Mod GRF is in Health Canada's Drug Product Database, and Health Canada has listed a seized vial labelled CJC-1295 separately from one labelled CJC-1295 DAC among unauthorized products. Source | Not approved |
| Cortagen | Not authorized | No Cortagen product is in the Health Canada Drug Product Database. Health Canada warns against all unauthorized injectable peptide drugs. Source | Not approved |
| DSIP (delta sleep-inducing peptide) | Not authorized | No DSIP or emideltide product in the Health Canada Drug Product Database. Health Canada names DSIP among unauthorized injectable peptide drugs it has seized. Source | Not approved |
| Epitalon | Not authorized | No epitalon product in the Health Canada Drug Product Database. Health Canada names Epitalon among unauthorized injectable peptide drugs it has seized. Source | Not approved |
| GHK-Cu | Not authorized | No GHK-Cu drug product is in Health Canada's Drug Product Database, and Health Canada names GHK-Cu among unauthorized injectable peptide drugs it has seized. Source | Not approved |
| GHRP-2 | Not authorized | No pralmorelin or GHRP-2 product, current or cancelled, is in Health Canada's Drug Product Database, and Health Canada has listed GHRP 2 among unauthorized injectable peptide drugs sold online. Source | Not approved |
| GHRP-6 | Not authorized | No GHRP-6 product, current or cancelled, is in Health Canada's Drug Product Database, and Health Canada has listed GHRP 6 among unauthorized injectable peptide drugs sold online. Source | Not approved |
| Gonadorelin | No longer sold | No authorized human gonadorelin product is being sold in Canada. The Drug Product Database lists Lutrepulse 3.2 mg/vial (DIN 02046202) as Dormant since 2017-04-21 and every other human gonadorelin product as Cancelled Post Market. Source | No longer sold |
| HCG | Authorized, prescription | Authorized by Health Canada. Pregnyl (Organon Canada) and Chorionic Gonadotropin for Injection, USP (Fresenius Kabi Canada) are listed as marketed, both as 10,000 unit vials. Source | Approved, prescription |
| HGH | Authorized, prescription | Authorized by Health Canada. Genotropin, Omnitrope, Saizen, Norditropin FlexPro and Serostim are listed as marketed in the Drug Product Database. Source | Approved, prescription |
| HGH Fragment 176-191 | Not authorized | No growth hormone fragment product is in Health Canada's Drug Product Database, and Health Canada lists HGH Fragment among unauthorized injectable peptide drugs seized from an online seller. Source | Not approved |
| HMG | Authorized, prescription | Authorized by Health Canada. Menopur 75 unit vials (Ferring Inc) are listed as marketed; Repronex was cancelled after market in 2019. Source | Approved, prescription |
| IGF-1 LR3 | Not authorized | No IGF-1 LR3 product is in Health Canada's Drug Product Database; the IGF-1 product it lists is Increlex (mecasermin, DIN 02509733), which is a different molecule. Source | Not approved |
| Ipamorelin | Not authorized | No ipamorelin product is in Health Canada's Drug Product Database, and Health Canada names ipamorelin among unauthorized injectable peptide drugs it has seized. Source | Not approved |
| Kisspeptin-10 | Not authorized | No kisspeptin product is in Health Canada's Drug Product Database. Health Canada has named kisspeptin and kisspeptin-10 among seized unauthorized injectable peptide drugs. Source | Not approved |
| KPV | Not authorized | Not authorized in Canada. Health Canada names KPV among unauthorized injectable peptide drugs it has seized (advisory of 9 April 2026). Source | Not approved |
| Livagen | Not authorized | No Livagen product is in the Health Canada Drug Product Database. Health Canada warns against all unauthorized injectable peptide drugs. Source | Not approved |
| LL-37 | Not authorized | Not authorized in Canada. Health Canada lists LL-37 among unauthorized injectable peptide drugs seized from an online seller (advisory of 1 August 2025). Source | Not approved |
| Melanotan II | Not authorized | Not authorized. Health Canada lists Melanotan I and II among unauthorized injectable peptide drugs it has seized and tells consumers not to buy or use them. Source | Not approved |
| MGF | Not authorized | No MGF product, current or cancelled, is in Health Canada's Drug Product Database. Injectable peptides are regulated as prescription drugs in Canada. Source | Not approved |
| MOTS-c | Not authorized | No MOTS-c product in the Health Canada Drug Product Database. Health Canada names MOTS-C among unauthorized injectable peptide drugs it has seized. Source | Not approved |
| NAD+ | Not authorized | No injectable NAD+ product in the Health Canada Drug Product Database. Health Canada names NAD+ among unauthorized injectable products it has seized, and a 2025 recall covered NAD+ solutions sold without market authorization. Source | Not approved |
| Pinealon | Not authorized | No Pinealon product is in Health Canada's Drug Product Database, and Health Canada lists Pinealon among unauthorized injectable peptide drugs seized from an online seller. Source | Not approved |
| PT-141 (bremelanotide) | Not authorized | No bremelanotide product is in Health Canada's Drug Product Database. Health Canada has named bremelanotide and PT-141 among seized unauthorized injectable peptide drugs. Source | Approved for one use |
| Retatrutide | Not authorized | No retatrutide product is in the Health Canada Drug Product Database. Health Canada lists retatrutide among unauthorized injectable peptide drugs it has seized. | Not approved, in trials |
| Selank | Not authorized | No Selank product in the Health Canada Drug Product Database. Health Canada named Selank among unauthorized injectable peptide drugs seized from an online seller. Source | Not approved |
| Semaglutide | Authorized, prescription | Authorized by Health Canada. Ozempic, Rybelsus and Wegovy are listed as marketed, and so are generic semaglutide injections from two companies. Source | Approved, prescription |
| Semax | Not authorized | No Semax product in the Health Canada Drug Product Database. Health Canada named Semax among unauthorized injectable peptide drugs seized from an online seller. Source | Not approved |
| Sermorelin | Not authorized | No sermorelin product, current or cancelled, is in Health Canada's Drug Product Database, and Health Canada has listed sermorelin among unauthorized injectable peptide drugs sold online. Source | No longer sold |
| SLU-PP-332 | Not authorized | No product is in the Health Canada Drug Product Database. A product labelled SLU-PP-332 was among unauthorized products Health Canada seized. Source | Not approved |
| SS-31 (elamipretide) | Not authorized | No elamipretide or Forzinity product in the Health Canada Drug Product Database. Health Canada names SS-31 among unauthorized injectable peptide drugs it has seized. Source | Approved for one use |
| TB-500 | Not authorized | Not authorized in Canada. Health Canada names TB-500 among unauthorized injectable peptide drugs it has seized (advisory of 9 April 2026). Source | Not approved |
| Tesamorelin | No longer sold | Not currently marketed in Canada: Egrifta DIN 02438712 (1 mg/vial) is Cancelled Post Market as of 2022-09-30 and DIN 02423677 (2 mg/vial) is Cancelled Pre Market as of 2023-07-13. Source | Approved for one use |
| Testagen | Not authorized | No Testagen product is in the Health Canada Drug Product Database. Health Canada warns against all unauthorized injectable peptide drugs. Source | Not approved |
| Thymosin Alpha-1 | Not authorized | Not authorized in Canada. No thymalfasin, thymosin or Zadaxin product is in the Drug Product Database, and Health Canada advisories list thymosin alpha among seized unauthorized injectable peptide drugs. Source | Not approved |
| Tirzepatide | Authorized, prescription | Authorized by Health Canada as Mounjaro and Zepbound, both listed as marketed in the Drug Product Database. Source | Approved, prescription |
| Vilon | Not authorized | No Vilon product is in the Health Canada Drug Product Database. Health Canada warns against all unauthorized injectable peptide drugs. Source | Not approved |
What the words mean
Authorized, prescription means Health Canada's Drug Product Database lists at least one marketed product that contains the peptide. It is a prescription medicine, and its dose is on the product monograph.
Not authorized means no marketed product was found in that database on the date shown. It says nothing more than that. It is not a statement about whether a substance is safe, and it is not legal advice about buying, importing or possessing it.
No longer sold means a product was once authorized and the database now lists it as cancelled or dormant.
Status changes. Each row links to the record that was opened, so it can be checked again.
Where Canada and the US differ
Most peptides on this site stand the same way in both countries. These do not:
- PT-141 (bremelanotide): US approved for one use, Canada not authorized
- SS-31 (elamipretide): US approved for one use, Canada not authorized
- Tesamorelin: US approved for one use, Canada no longer sold
Even where both countries have an approved product, the labels can differ. The dosage page for each peptide notes it when the maximum dose or the approved use is not the same.
Related
Dosages A to ZSources and correctionsEditorial policy
DosageFacts is an information site. It is not medical advice. Talk to a licensed professional before using any medication.